23 November 2015 - Amgen today announced that CVS Health will provide preferred access to Repatha (evolocumab) through its CVS/caremark commercial formularies.

For more details, go to: http://www.amgen.com/media/news-releases/2015/11/amgen-announces-repatha-preferred-position-on-cvs-health-commercial-formularies/